This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, V. P.
Right arrow Articles by Alcami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, V. P.
Right arrow Articles by Alcami, A.

 Previous Article  |  Next Article 

Journal of Virology, February 2002, p. 1124-1134, Vol. 76, No. 3
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.3.1124-1134.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Inhibition of Interferons by Ectromelia Virus

Vincent P. Smith and Antonio Alcami*

Division of Virology, Department of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom

Received 2 July 2001/ Accepted 31 October 2001

Ectromelia virus (EV) is an orthopoxvirus (OPV) that causes mousepox, a severe disease of laboratory mice. Mousepox is a useful model of OPV infection because EV is likely to be a natural mouse pathogen, unlike its close relatives vaccinia virus (VV) and variola virus. Several studies have highlighted the importance of mouse interferons (IFNs) in resistance to and recovery from EV infection, but little is known of the anti-IFN strategies encoded by the virus itself. We have determined that 12 distinct strains and isolates of EV encode soluble, secreted receptors for IFN-{gamma} (vIFN-{gamma}R) and IFN-{alpha}/ß (vIFN-{alpha}/ßR) that are homologous to those identified in other OPVs. We demonstrate for the first time that the EV vIFN-{gamma}R has the unique ability to inhibit the biological activity of mouse IFN-{gamma}. The EV vIFN-{alpha}/ßR was a potent inhibitor of human and mouse IFN-{alpha} and human IFN-ß but, surprisingly, was unable to inhibit mouse IFN-ß. The replication of all of the EVs included in our study and of cowpox virus was more resistant than VV to the antiviral effects induced in mouse L-929 cells by IFN-{alpha}/ß and IFN-{gamma}. Sequencing studies showed that this EV resistance is likely to be partly mediated by the double-stranded-RNA-binding protein encoded by an intact EV homolog of the VV E3L gene. The absence of a functional K3L gene, which encodes a viral eIF-2{alpha} homolog, in EV suggests that the virus encodes a novel mechanism to counteract the IFN response. These findings will facilitate future studies of the role of viral anti-IFN strategies in mousepox pathogenesis. Their significance in the light of earlier data on the role of IFNs in mousepox is discussed.

* Corresponding author. Mailing address: Division of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, United Kingdom. Phone: 44 (1223) 336922. Fax: 44 (1223) 336926. E-mail: aa258{at}mole.bio.cam.ac.uk.

Journal of Virology, February 2002, p. 1124-1134, Vol. 76, No. 3
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.3.1124-1134.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Waibler, Z., Anzaghe, M., Frenz, T., Schwantes, A., Pohlmann, C., Ludwig, H., Palomo-Otero, M., Alcami, A., Sutter, G., Kalinke, U. (2009). Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components. J. Virol. 83: 1563-1571 [Abstract] [Full Text]  
  • Xu, R.-H., Cohen, M., Tang, Y., Lazear, E., Whitbeck, J. C., Eisenberg, R. J., Cohen, G. H., Sigal, L. J. (2008). The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. JEM 205: 981-992 [Abstract] [Full Text]  
  • Domingo-Gil, E., Perez-Jimenez, E., Ventoso, I., Najera, J. L., Esteban, M. (2008). Expression of the E3L Gene of Vaccinia Virus in Transgenic Mice Decreases Host Resistance to Vaccinia Virus and Leishmania major Infections. J. Virol. 82: 254-267 [Abstract] [Full Text]  
  • Huang, J., Smirnov, S. V., Lewis-Antes, A., Balan, M., Li, W., Tang, S., Silke, G. V., Putz, M. M., Smith, G. L., Kotenko, S. V. (2007). Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc. Natl. Acad. Sci. USA 104: 9822-9827 [Abstract] [Full Text]  
  • Sakala, I. G., Chaudhri, G., Buller, R. M., Nuara, A. A., Bai, H., Chen, N., Karupiah, G. (2007). Poxvirus-Encoded Gamma Interferon Binding Protein Dampens the Host Immune Response to Infection. J. Virol. 81: 3346-3353 [Abstract] [Full Text]  
  • Esteban, D. J., Buller, R. M. L. (2005). Ectromelia virus: the causative agent of mousepox. J. Gen. Virol. 86: 2645-2659 [Abstract] [Full Text]  
  • Panchanathan, V., Chaudhri, G., Karupiah, G. (2005). Interferon function is not required for recovery from a secondary poxvirus infection. Proc. Natl. Acad. Sci. USA 102: 12921-12926 [Abstract] [Full Text]  
  • Krzyzowska, M., Polanczyk, M., Bas, M., Cymerys, J., Schollenberger, A., Chiodi, F., Niemialtowski, M. (2005). Mousepox conjunctivitis: the role of Fas/FasL-mediated apoptosis of epithelial cells in virus dissemination. J. Gen. Virol. 86: 2007-2018 [Abstract] [Full Text]  
  • Nathaniel, R., MacNeill, A. L., Wang, Y.-X., Turner, P. C., Moyer, R. W. (2004). Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J. Gen. Virol. 85: 1267-1278 [Abstract] [Full Text]  
  • Reading, P. C., Smith, G. L. (2003). Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity. J. Virol. 77: 9960-9968 [Abstract] [Full Text]  
  • Ribas, G., Rivera, J., Saraiva, M., Campbell, R. D., Alcami, A. (2003). Genetic Variability of Immunomodulatory Genes in Ectromelia Virus Isolates Detected by Denaturing High-Performance Liquid Chromatography. J. Virol. 77: 10139-10146 [Abstract] [Full Text]  
  • Johnston, J. B., McFadden, G. (2003). Poxvirus Immunomodulatory Strategies: Current Perspectives. J. Virol. 77: 6093-6100 [Full Text]  
  • Saraiva, M., Smith, P., Fallon, P. G., Alcami, A. (2002). Inhibition of Type 1 Cytokine-mediated Inflammation by a Soluble CD30 Homologue Encoded by Ectromelia (Mousepox) Virus. JEM 196: 829-839 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»